LAKE OSWEGO, OR, April 6, 2018  Medica Holdings, Inc. is pleased to announce that the Medicant Mucosal Atomizer (MMA), has received 510(k) clearance from the United States Food & Drug Administration (FDA). The MMA allows for the non-invasive delivery of medication directly to a patient’s blood stream via their mucosal membranes.  The device will be available in three styles; MMA Rhinal™ for nasal applications, 4.5” and 8.5” for delivery directly to the laryngo-tracheal region via a wand-like configuration. The MMA Rhinal™ is for use with drugs approved for intranasal delivery, all supplied with a 3 cc syringe.

​LAKE OSWEGO, OR, February 21, 2017 -- Medica Holdings, Inc. has received FDA clearance (K163091) for its VibraPEP® Oscillatory PEP (OPEP) System expanding the indications for use to include connecting a Valved Tee Adapter for use with a jet nebulizer for aerosol drug delivery.  This combination of aerosol treatments with OPEP saves time and enhances medication deposition.

​LAKE OSWEGO, OR, March 25, 2016 -- Medica Holdings, LLC has received FDA clearance (K153441) for its VibraPEP® Oscillatory PEP (OPEP) System.  The VibraPEP™ Mucus Clearing Device is a Positive Expiratory Pressure, PEP Device. It was designed to exercise patient's lungs and to improve secretion clearance.